These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 25715938

  • 1. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
    Pöss J, Ewen S, Schmieder RE, Muhler S, Vonend O, Ott C, Linz D, Geisel J, Rump LC, Schlaich M, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2015 Aug; 104(8):672-8. PubMed ID: 25715938
    [Abstract] [Full Text] [Related]

  • 2. Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension.
    Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE.
    Clin Res Cardiol; 2018 Jan; 107(1):42-48. PubMed ID: 28845508
    [Abstract] [Full Text] [Related]

  • 3. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 4. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M.
    JACC Cardiovasc Interv; 2015 Jun; 8(7):972-80. PubMed ID: 26003031
    [Abstract] [Full Text] [Related]

  • 5. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 6. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K, Heinemann D, Okon T, Röhnert K, Stiermaier T, von Röder M, Besler C, Müller U, Höllriegel R, Schuler G, Desch S, Lurz P.
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [Abstract] [Full Text] [Related]

  • 7. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 8. Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension.
    Lipphardt M, Koziolek MJ, Lehnig LY, Schäfer AK, Müller GA, Lüders S, Wallbach M.
    Clin Res Cardiol; 2019 Nov; 108(11):1287-1296. PubMed ID: 30955077
    [Abstract] [Full Text] [Related]

  • 9. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
    Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.
    Catheter Cardiovasc Interv; 2015 Aug 10; 86(2):299-303. PubMed ID: 23983010
    [Abstract] [Full Text] [Related]

  • 11. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
    Vogel B, Kirchberger M, Zeier M, Stoll F, Meder B, Saure D, Andrassy M, Mueller OJ, Hardt S, Schwenger V, Strothmeyer A, Katus HA, Blessing E.
    Clin Res Cardiol; 2014 Feb 10; 103(2):117-24. PubMed ID: 24126436
    [Abstract] [Full Text] [Related]

  • 12. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C.
    Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527
    [Abstract] [Full Text] [Related]

  • 13. Salt intake and blood pressure response to percutaneous renal denervation in resistant hypertension.
    de Beus E, de Jager RL, Beeftink MM, Sanders MF, Spiering W, Vonken EJ, Voskuil M, Bots ML, Blankestijn PJ, SYMPATHY study group.
    J Clin Hypertens (Greenwich); 2017 Nov 15; 19(11):1125-1133. PubMed ID: 28929577
    [Abstract] [Full Text] [Related]

  • 14. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul 15; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 15. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium.
    Blood Press; 2015 Jul 15; 24(5):263-74. PubMed ID: 26194721
    [Abstract] [Full Text] [Related]

  • 16. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul 15; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal denervation in hypertensive patients not on blood pressure lowering drugs.
    De Jager RL, Sanders MF, Bots ML, Lobo MD, Ewen S, Beeftink MM, Böhm M, Daemen J, Dörr O, Hering D, Mahfoud F, Nef H, Ott C, Saxena M, Schmieder RE, Schlaich MP, Spiering W, Tonino PA, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Worthley SG, Blankestijn PJ.
    Clin Res Cardiol; 2016 Sep 15; 105(9):755-62. PubMed ID: 27105858
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 15; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.